about
Chronic Lyme disease: a reviewComprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseasesCharacterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesTick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, USAInvariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia.Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitisSingle-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.Treatment trials for post-Lyme disease symptoms revisited.Rapid, simple, quantitative, and highly sensitive antibody detection for lyme diseaseEvaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndromeLyme disease: an update.Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.Long-term persistence of zoster vaccine efficacyLaboratory diagnosis of Lyme disease: advances and challengesPersistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome.Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.Relapsing fever borreliosis in interleukin-10-deficient miceSafety of zoster vaccine in elderly adults following documented herpes zosterC6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis.Interleukin 10 protects the brain microcirculation from spirochetal injuryNatural killer cell counts are not different between patients with post-Lyme disease syndrome and controls.Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.IL-10 helps control pathogen load during high-level bacteremia.Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.Lyme Neuroborreliosis.High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae.Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.Citrate anticoagulant improves the sensitivity of Borreliella (Borrelia) burgdorferi plasma culture.Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology.Early Disseminated Lyme Disease Causing False Positive Serology for Primary Epstein-Barr Virus Infection - Report of 2 Cases.Reply to Naktin.Cross-Species Interferon Signaling Boosts Microbicidal Activity within the Tick Vector.Advances in the treatment of chronic hepatitis B virus infection.Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.
P50
Q22252200-DABAE949-E7F8-4C9C-A7EB-DA98363699B6Q24273331-E1B5C976-D053-4BF4-BF52-204900C75A58Q24617384-5AF85D1B-77D2-47A5-8E3D-3EE77C345F94Q24654159-B1A2231A-FAA7-4560-888D-4047DEED94F7Q30416325-8955116F-B097-491C-8C7B-9700BE4E2372Q33261311-803A0708-082B-4D8A-8322-39C5FC2BA1FBQ33738269-86934734-F052-4A77-AF56-FE3545518C5EQ33822701-E290FEEF-A29F-40E6-8D66-28BB2E8039BCQ33909157-D48AE92F-62A9-4682-B363-3CDD059F24FDQ33962743-94A2F253-EFA4-426E-AB80-3BF4B9C95F11Q33964217-DC2A6187-E55A-49F5-B684-599579B1325CQ34202515-CE737000-1AF2-4ACD-B87E-AB71CF16C8C9Q34561831-998813F2-F725-4DEC-8DE9-54CC2F5665B1Q35066111-7EB1D64C-F5DD-4CB5-A40D-907E0848F91BQ35099146-6268E7BF-C167-4799-A5BD-8AF9A4CA9365Q35171857-EE30BAFE-8E55-42BA-AB18-8FDD072F512FQ35638551-3051D34C-1FED-44C9-848B-066D588208E1Q35975369-6A6B3CD3-119A-4890-9357-A0DC8AF83180Q36276196-EEB613A8-E67B-41D6-BC80-92640AC81D18Q36489385-763475AC-0D9B-46F4-B642-2F08B1879B19Q36948131-BC2BD9C7-0DB9-4A39-B6E2-CA74123FD414Q36974418-6C2C0976-2D95-42AD-AF90-FE516925A821Q37037021-BD3F6094-8933-433D-8FBD-E1C30A117118Q37058167-B30AA593-8A3F-41FB-8095-3FDC18C43F81Q37267014-9D70CDBD-E0A1-4CEF-944B-6384DD84C65EQ37301848-F658DEE5-F7D0-4FA0-87F0-DD2F9EA67654Q37410629-930B3619-9584-48ED-BE48-C11AA47F44B0Q37476110-5C952C66-A5D8-49FC-B448-C0CB1FE05502Q37635036-6F20EECB-0F91-4D39-B172-EB41AB4FF3E7Q38658192-0E2C54C2-120A-4C4C-BFDA-D1C1556C3251Q39020133-1FDE9553-C84F-409D-9204-28CD21E93F8FQ39431370-0B49D8B9-1514-44C5-8091-E984EA8C1A44Q40063947-4E05E951-B7EE-440D-84D8-2A7149B5E4AEQ40096920-8B5E2F2F-BBC3-46B1-94E2-CA7FAE20D845Q40257045-1814904C-458E-46C2-B261-595E0C13689CQ40283603-4CB4809E-07D3-49D2-B8BF-D904AA629022Q40626873-9F381889-93E2-44EA-9878-43ECF0877D71Q45748510-9F0F25F9-44A2-44DC-B604-38FF963C1958Q46836151-9774944D-C6D4-42E7-9532-8C3DAC3B4FD7Q47223317-C4AF0B3C-D5A1-436B-9BB0-28871EABB4A6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adriana Marques
@ast
Adriana Marques
@en
Adriana Marques
@es
Adriana Marques
@nl
Adriana Marques
@sl
type
label
Adriana Marques
@ast
Adriana Marques
@en
Adriana Marques
@es
Adriana Marques
@nl
Adriana Marques
@sl
prefLabel
Adriana Marques
@ast
Adriana Marques
@en
Adriana Marques
@es
Adriana Marques
@nl
Adriana Marques
@sl
P106
P1153
7202134750
P21
P31
P496
0000-0002-5403-4551